{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:09:58Z","timestamp":1789560598830,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032767","name":"Sichuan Medical Association","doi-asserted-by":"publisher","award":["2023TG02"],"award-info":[{"award-number":["2023TG02"]}],"id":[{"id":"10.13039\/100032767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cyto.2026.157203","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:58:07Z","timestamp":1787648287000},"page":"157203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combinatorial therapy of LL-37 and ADSCs accelerates diabetic wound repair by orchestrating NRROS-mediated crosstalk between TGF-\u03b2\/SMAD and hippo\/TEAD1 axes"],"prefix":"10.1016","volume":"207","author":[{"given":"Ling","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157203_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112158","article-title":"IDF global clinical practice recommendations for managing type 2 diabetes - 2025","author":"Schwarz","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.cyto.2026.157203_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.cyto.2026.157203_bb0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/medicina57101072","article-title":"Diabetic wound-healing science","volume":"57","author":"Burgess","year":"2021","journal-title":"Medicina"},{"issue":"3 Suppl","key":"10.1016\/j.cyto.2026.157203_bb0020","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/j.jvs.2010.06.003","article-title":"The costs of diabetic foot: the economic case for the limb salvage team","volume":"52","author":"Driver","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"3","key":"10.1016\/j.cyto.2026.157203_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0041-1731460","article-title":"Updates in diabetic wound healing, inflammation, and scarring","volume":"35","author":"Dasari","year":"2021","journal-title":"Semin. Plast. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2026.157203_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/iwj.12187","article-title":"Surgical debridement to optimise wound conditions and healing","volume":"10","author":"Diefenbeck","year":"2013","journal-title":"Int. Wound J."},{"issue":"2","key":"10.1016\/j.cyto.2026.157203_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/wrr.12994","article-title":"Chronic wounds: treatment consensus","volume":"30","author":"Eriksson","year":"2022","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.cyto.2026.157203_bb0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.biopha.2018.08.013","article-title":"Adipose-derived stem cells: effectiveness and advances in delivery in diabetic wound healing","volume":"107","author":"Gadelkarim","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cyto.2026.157203_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics14010001","article-title":"Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation","volume":"14","author":"Dzurov\u00e1","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"10.1016\/j.cyto.2026.157203_bb0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"D\u00fcrr","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cyto.2026.157203_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107398","article-title":"LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity","volume":"65","author":"Keshri","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cyto.2026.157203_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00143","article-title":"The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds","volume":"4","author":"Duplantier","year":"2013","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157203_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/wrr.12211","article-title":"Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial","volume":"22","author":"Gr\u00f6nberg","year":"2014","journal-title":"Wound Repair Regen."},{"issue":"3","key":"10.1016\/j.cyto.2026.157203_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1523-1747.2003.12069.x","article-title":"The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium","volume":"120","author":"Heilborn","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2026.157203_bb0075","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1167\/iovs.09-3904","article-title":"LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas","volume":"51","author":"Yin","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.cyto.2026.157203_bb0080","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.175.7.4662","article-title":"Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37","volume":"175","author":"Tokumaru","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2026.157203_bb0085","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00403-023-02657-8","article-title":"Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial","volume":"315","author":"Miranda","year":"2023","journal-title":"Arch. Dermatol. Res."},{"issue":"12","key":"10.1016\/j.cyto.2026.157203_bb0090","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V97.12.3951","article-title":"Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3","volume":"97","author":"S\u00f8rensen","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cyto.2026.157203_bb0095","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157203_bb0100","series-title":"Immunomodulatory Effects of LL-37 in the Epithelia[D]","author":"Filewod","year":"2008"},{"issue":"9","key":"10.1016\/j.cyto.2026.157203_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091316","article-title":"Epithelial-immune cell crosstalk determines the activation of immune cells in vitro by the human cathelicidin LL-37 at low physiological concentrations","volume":"13","author":"Bogdanov","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cyto.2026.157203_bb0110","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1167\/iovs.05-1649","article-title":"Multifunctional roles of human cathelicidin (LL-37) at the ocular surface","volume":"47","author":"Huang","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cyto.2026.157203_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0448-3","article-title":"LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells","volume":"7","author":"Oliveira-Bravo","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.cyto.2026.157203_bb0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/leu.2011.252","article-title":"The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation","volume":"26","author":"Wu","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cyto.2026.157203_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/biof.1225","article-title":"Unique features of human cathelicidin LL-37","volume":"41","author":"Bandurska","year":"2015","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.cyto.2026.157203_bb0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3346\/jkms.2005.20.4.649","article-title":"Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases","volume":"20","author":"Kim","year":"2005","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2026.157203_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/096368915X687921","article-title":"Adipose-derived stem cells accelerate diabetic wound healing through the induction of autocrine and paracrine effects","volume":"25","author":"Kuo","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/j.cyto.2026.157203_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-3701-5-3","article-title":"Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro","volume":"5","author":"Wang","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cyto.2026.157203_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2020.100037","article-title":"The role of extracellular matrix in the pathophysiology of diabetic wounds","volume":"6-7","author":"Huang","year":"2020","journal-title":"Matrix Biol. Plus"},{"key":"10.1016\/j.cyto.2026.157203_bb0150","series-title":"The Diabetic Foot. Contemporary Diabetes","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-55715-6_7","article-title":"Physiology and pathophysiology of wound healing in diabetes","author":"Pastar","year":"2024"},{"key":"10.1016\/j.cyto.2026.157203_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107860","article-title":"Fidelity of long-term cryopreserved adipose-derived stem cells for differentiation into cells of ocular and other lineages","volume":"189","author":"Kumar","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.cyto.2026.157203_bb0160","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.3390\/ph3113435","article-title":"Spotlight on human LL-37, an immunomodulatory peptide with promising cell-penetrating properties","volume":"3","author":"Seil","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.cyto.2026.157203_bb0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.109.881441","article-title":"Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells","volume":"122","author":"Leeper","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cyto.2026.157203_bb0170","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/ATVBAHA.113.301851","article-title":"Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin","volume":"33","author":"Salvado","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.cyto.2026.157203_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101416","article-title":"Modeling the control of TGF-\u03b2\/Smad nuclear accumulation by the hippo pathway effectors, Taz\/Yap","volume":"23","author":"Labibi","year":"2020","journal-title":"iScience"},{"issue":"21","key":"10.1016\/j.cyto.2026.157203_bb0180","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.jmb.2015.04.015","article-title":"Crosstalk between hippo and TGF\u03b2: subcellular localization of YAP\/TAZ\/Smad complexes","volume":"427","author":"Grannas","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157203_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1060","article-title":"TGF-\u03b2\/Smads signaling pathway, hippo-YAP\/TAZ signaling pathway, and VEGF: their mechanisms and roles in vascular remodeling related diseases","volume":"11","author":"Liu","year":"2023","journal-title":"Immun Inflamm Dis."},{"key":"10.1016\/j.cyto.2026.157203_bb0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aau2909","article-title":"Structural basis of latent TGF-\u03b21 presentation and activation by GARP on human regulatory T cells","volume":"362","author":"Li\u00e9nart","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cyto.2026.157203_bb0195","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1038\/s41467-022-32655-9","article-title":"Specificity of TGF-\u03b21 signal designated by LRRC33 and integrin \u03b1V\u03b28","volume":"13","author":"Duan","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cyto.2026.157203_bb0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","article-title":"Wound healing, fibroblast heterogeneity, and fibrosis","volume":"29","author":"Talbott","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.cyto.2026.157203_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081959","article-title":"Mesenchymal stem cell-derived exosomes: applications in regenerative medicine","volume":"10","author":"Hade","year":"2021","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.cyto.2026.157203_bb0210","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1089\/scd.2017.0087","article-title":"Bone marrow mesenchymal stem cell-derived CD63+ exosomes transport Wnt3a exteriorly and enhance dermal fibroblast proliferation, migration, and angiogenesis in vitro","volume":"26","author":"McBride","year":"2017","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.cyto.2026.157203_bb0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.21037\/cdt-20-1032","article-title":"Exosomes derived from human amniotic fluid mesenchymal stem cells alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro","volume":"11","author":"Hu","year":"2021","journal-title":"Cardiovasc Diagn Ther."},{"issue":"3","key":"10.1016\/j.cyto.2026.157203_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12993","article-title":"Exosomes from adipose-derived stem cells and application to skin wound healing","volume":"54","author":"An","year":"2021","journal-title":"Cell Prolif."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:48:18Z","timestamp":1789559298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S1043466626000980"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157203","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial therapy of LL-37 and ADSCs accelerates diabetic wound repair by orchestrating NRROS-mediated crosstalk between TGF-\u03b2\/SMAD and hippo\/TEAD1 axes","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157203"}}